Free Trial

Janus Henderson Group PLC Grows Stake in UFP Technologies, Inc. (NASDAQ:UFPT)

UFP Technologies logo with Industrials background

Janus Henderson Group PLC grew its stake in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 29.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,860 shares of the industrial products company's stock after acquiring an additional 7,008 shares during the quarter. Janus Henderson Group PLC owned 0.40% of UFP Technologies worth $7,546,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the stock. AlphaQuest LLC bought a new position in shares of UFP Technologies during the fourth quarter valued at $25,000. Johnson Financial Group Inc. bought a new position in shares of UFP Technologies during the fourth quarter valued at $42,000. Venturi Wealth Management LLC bought a new position in shares of UFP Technologies during the fourth quarter valued at $74,000. EverSource Wealth Advisors LLC lifted its holdings in shares of UFP Technologies by 24.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 333 shares of the industrial products company's stock valued at $81,000 after purchasing an additional 66 shares in the last quarter. Finally, KBC Group NV lifted its holdings in shares of UFP Technologies by 37.9% during the fourth quarter. KBC Group NV now owns 375 shares of the industrial products company's stock valued at $92,000 after purchasing an additional 103 shares in the last quarter. 87.28% of the stock is owned by institutional investors.

UFP Technologies Stock Performance

UFP Technologies stock traded down $10.10 during mid-day trading on Wednesday, reaching $229.20. 82,536 shares of the stock traded hands, compared to its average volume of 85,802. The stock has a market capitalization of $1.77 billion, a PE ratio of 32.70 and a beta of 1.10. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.57 and a quick ratio of 1.43. UFP Technologies, Inc. has a 12-month low of $178.26 and a 12-month high of $366.41. The business's 50-day moving average is $212.97 and its 200-day moving average is $249.18.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The industrial products company reported $2.47 EPS for the quarter, beating analysts' consensus estimates of $2.05 by $0.42. The company had revenue of $148.15 million during the quarter, compared to analysts' expectations of $139.93 million. UFP Technologies had a return on equity of 18.92% and a net margin of 11.74%.

Analyst Upgrades and Downgrades

UFPT has been the topic of a number of research analyst reports. Lake Street Capital set a $252.00 price target on UFP Technologies and gave the company a "buy" rating in a report on Wednesday, May 7th. StockNews.com downgraded UFP Technologies from a "hold" rating to a "sell" rating in a report on Thursday, January 23rd. Finally, Raymond James initiated coverage on UFP Technologies in a research report on Friday, March 28th. They set a "market perform" rating for the company.

Read Our Latest Stock Analysis on UFP Technologies

Insider Activity at UFP Technologies

In other UFP Technologies news, Director Daniel C. Croteau sold 6,846 shares of the company's stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $228.41, for a total value of $1,563,694.86. Following the completion of the sale, the director now owns 1,785 shares in the company, valued at $407,711.85. This represents a 79.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Christopher P. Litterio sold 1,473 shares of the company's stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $220.12, for a total value of $324,236.76. Following the completion of the sale, the senior vice president now owns 12,585 shares of the company's stock, valued at approximately $2,770,210.20. The trade was a 10.48% decrease in their position. The disclosure for this sale can be found here. 4.40% of the stock is owned by company insiders.

UFP Technologies Profile

(Free Report)

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.

See Also

Institutional Ownership by Quarter for UFP Technologies (NASDAQ:UFPT)

Should You Invest $1,000 in UFP Technologies Right Now?

Before you consider UFP Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UFP Technologies wasn't on the list.

While UFP Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines